Document is current
Any future updates will be listed below
-
Authors
García-Olmo, D. https://orcid.org/0000-0002-9369-2338
Gómez-Barrera, M. https://orcid.org/0000-0001-8357-1279
de la Portilla, F. https://orcid.org/0000-0003-0603-2911
-
Funding
Funding for this research was provided by:
Takeda Farmacéutica España SA
- License Information
-
More Information
Article History
Received: 14 July 2022
Accepted: 10 January 2023
First Online: 5 February 2023
Declarations
:
: Not applicable, it is a systematic review.
: Not applicable.
: MGB develop their professional activity at PORIB, a consulting firm specialized in the economic evaluation of health technologies that has received remuneration from Takeda Farmacéutica España S.A., Spain for the realization of this project. Remuneration was not received for participation as an author during manuscript development. DGO and FP have received fees for conferences and educational activities of Takeda Farmacéutica España S.A. DGO, MGB and FP declare that the financial support has not interfered with the development of the work.
